Navigation Links
Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine
Date:12/12/2010

NEW YORK, Dec. 12, 2010 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today.  The AMC is an innovative program which involves private-public partnerships to help make newer vaccines available on a sustainable, affordable and accelerated basis to the least developed countries.

(Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO)

"Pfizer remains steadfast in its commitment to accelerate global access to its vaccines and medicines; public-private partnerships such as those that underpin the AMC are a great example of how to make critical progress in that area," says Mark Swindell, president, Pfizer Vaccines.  "It truly is historic to see a new vaccine such as Prevenar 13 launched in a developing country within one year of its introduction in the U.S. and Europe, given the previous average 15-year gap between introduction of new vaccines in developed and developing countries."

Prevenar 13 provides coverage against the 13 most prevalent invasive pneumococcal disease-causing strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) in infants and young children worldwide.  Prevenar 13 is the only pneumococcal conjugate vaccine available under the AMC that is prequalified by the World Health Organization (WHO) for use in children through 5 years of age and to help prevent pneumonia caused by the 13 serotypes contained in the vaccine.

About the AMC

In March 2010, Pfizer entered into a 10-year agreement to provide Prevenar 13 to infants and young chil
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Younger Adults Increasingly Treated for Heart Disease-related Conditions
2. New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
3. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
4. Mayo Clinic Study Identifies Potential Causes of Young-Onset Dementia
5. St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors
6. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
7. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
8. Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
9. Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
10. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
11. Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , Mar. 05, 2015 Research and ... the addition of the "Global Pharma US ... Cost Optimization Plays Major Role In Shaping Up ... to their offering. Strategy Diversification ... in healthy Cash position- Will accelerate Next wave ...
(Date:3/5/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... Conference, to be held March 8-11, 2015, in ... James Sapirstein , Chief Executive Officer, will provide an ... and will be available to participate in one-on-one meetings ...
(Date:3/5/2015)... MENLO PARK, Calif. , March 5, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... one of the nation,s top rehabilitation hospitals for spinal ... the Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor ... complete cervical spinal cord injury (SCI). ...
Breaking Medicine Technology:Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
... Thousand Oaks, Calif. and BRUSSELS, July 5, 2011 Amgen ... announced today that they are collaborating with the National Aeronautics ... preclinical test of a sclerostin antibody in an experiment that ... NASA shuttle mission, Space Shuttle Flight STS-135, scheduled to launch ...
... a Los Angeles-based neuromodulation company, today announced that ... external Trigeminal Nerve Stimulation (eTNS™) increased regional cerebral ... and mood regulation.  eTNS™ was shown to be ... in depression severity during the 8-week adjunctive treatment ...
Cached Medicine Technology:Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 2Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 3Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 4Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 5Amgen and UCB Team Up With NASA on Final Space Shuttle Mission to Conduct Preclinical Test of Sclerostin Antibody on Bone Loss 6Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™ 2Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™ 3Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™ 4
(Date:3/5/2015)... In 2014, the FDA approved 44 drugs, with ... scoring 4 drug approvals in the USA. The infectious ... drug products, followed by oncology therapy with 18% of ... CDK inhibitors keep on attracting large-cap pharmacos. Nivolumab and ... metastatic melanoma, and at present, they are being investigated ...
(Date:3/5/2015)... 2015 AxoGen, Inc. (NASDAQ: AXGN) ... peripheral nerve repair market, reported record revenue of $4.79 ... compared to $2.98 million in the year-ago fourth quarter ... , “Our strong fourth quarter revenue growth reflects ... products which is driving increased surgeon adoption of our ...
(Date:3/5/2015)... March 05, 2015 HomeCEUConnection.com ... March with extra savings on their nutrition ... of health and nutrition, HomeCEUConnection.com is offering ... the promo code, NUTRITION2015 . , ... , HomeCEUConnection.com provides high-quality continuing education ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 TCS Healthcare ... solutions for the population health management arena, is pleased ... case management software, ACUITY Advanced Care™ (ACUITY) version 7.20. ... improved performance and the advantages of automation. , The ... ET, will be led by Jeff Frater, RN, BSN, ...
(Date:3/5/2015)... 05, 2015 University of Western ... in 1904, has launched a new center of ... changes. The Northwest Center for Lifestyle and Functional ... community outreach, and conduct research in the areas ... and nutrition. The center will target efforts on ...
Breaking Medicine News(10 mins):Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... living only days longer despite treatment advances, study finds , ... preterm babies in England have not improved over the past ... active treatment, a new study shows. , Researchers analyzed the ... of pregnancy, which is considered to be at the "margins ...
... dismiss need for long-term antibiotic therapy, but opponents call ... News) -- After more than a year of study, ... of America has decided that controversial guidelines for the ... be changed. , The guidelines, first adopted in 2006, ...
... ... pre-event for the American Cancer Society’s highly anticipated “Starry Night Gala” that will occur ... ... 21, 2010 -- “An Evening of Hope” is the official pre-event for the ...
... ... , ... prevention and management has come a long way in the last few decades. Advent of ... evil monster., , ,We are excited though to tell about the latest technique Dr. Khanna ...
... didn,t make a difference, study finds , THURSDAY, April ... to wait longer for diagnosis and treatment than white ... finds. , Researchers from the GW Cancer Institute looked ... 1997 and 2009 at seven hospitals and clinics in ...
... Employees hold fundraiser ... ... the recovery efforts in Haiti, AthletiCo Physical and Occupational Therapy held a special jean ... from the event is being donated to Partners in Health Stand with Haiti . ...
Cached Medicine News:Health News:Youngest Preemies' Survival Rate Unchanged 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 2Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 3Health News:Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged 4Health News:“An Evening Of Hope” - Tonight is the Official Pre-Event for this Year's American Cancer Society Starry Night Gala 2Health News:Glued graft for Pterygium Yield Better Cosmetic Results 2Health News:Glued graft for Pterygium Yield Better Cosmetic Results 3Health News:Black Women Wait Longer for Breast Cancer Diagnosis, Treatment 2Health News:AthletiCo Physical and Occupational Therapy Supports Partners in Health Stand with Haiti 2
... Technologies, The UroMax Ultra ia designed ... high pressure and low profile., Refolding ... a remarkably strong material that is ... materials., Non-Compliant Balloons, A compliant balloon ...
... Fr Diameter with Two Large Working Channels; ... MICRO-6 Semi-Rigid Ureteroscope is the smallest ureteroscope ... and therapeutic procedures. The ACMI MICRO-6 Ureteroscope ... procedures with minimal or no dilation or ...
... is a self-dilating, semi-rigid autoclavable operating ureteroscope ... image bundle for an enhanced, clear image. ... to "0" diopters. The direction of view ... passage. The straight access operating channel is ...
... tip diameter of only 6.9Fr (2.3mm) ... range of 180 for and easy ... observation, a new optical system has ... (3.9mm) sheath dilator, 0.035" guidewire compatible, ...
Medicine Products: